Dietary supplements are products containing concentrated sources of nutrients or other substances such as vitamins, minerals, products of animal origin, amino acids, metabolites, etc. The definition of these products is different according to the country. In China they are called Health food, in the EU –...
Read More
In this article we will give some clarifications on the use of global vs national standards for the codification of medicinal products to implement the EU Falsified Medicine Directive (EU FMD) in France. Background In 2019, GS1 adopted rules for ensuring unique identification and integrity in its...
Read More
Discover the requirements and deadlines for Uzbekistan, Kazakhstan and Kyrgyzstan. Download the whitepaper now by filling in the fields below: [contact-form-7 id="266e083" title="Contact form - CIS whitepaper"]...
Read More
A GTIN number in the pharma industry is like a product barcode, used for tracking and identification. It's a unique code assigned to each medicine or package to help manage the supply chain. In this second article dedicated to GS1 Standards, we will give you valuable...
Read More
In July 2023 the Republic of Kazakhstan announced a comprehensive strategy for introducing labeling and traceability of medicines. The aim is to enhance transparency, accountability, and efficiency in the pharmaceutical sector. The plan uses a series of organized actions, including changing rules, sharing data, and giving...
Read More
The pharmaceutical industry's journey toward sustainability involves implementing practices and strategies that minimize its environmental impact while continuing to advance medical science and patient care. Recognizing the importance of sustainability, many pharmaceutical companies are now striving to strike a balance between their business objectives and their...
Read More
Global standards such as GS1 are essential for the efficiency of healthcare systems. They are important for improving patient safety and well-being. The power of standardization and the benefits of efficient data exchange is doubtless. The fundamental concept driving GS1 standards is to facilitate transparency within...
Read More
In July 2023, the Minister of Economy and Commerce in Libya issued Decision No. 379 of 2023 requiring the application of a GS1 DataMatrix on pharmaceutical products and medical equipment supplied to the Libyan market. The path of barcoding of pharmaceuticals and medical devices Decision No. 379...
Read More
Introducing the second article of the series on Africa's Track and Trace Compliance landscape. In this paper we will look through the Track and trace systems in Zambia, Botswana and South Africa. Zambia In late October 2021, the Zambia Medicines Regulatory Authority (ZAMRA) published a draft Guideline...
Read More
JFDA extended the implementation deadline for DataMatrix and serialization on secondary packaging on regulated pharmaceutical products until 30 September 2023. Journey towards traceability implementation Jordan announced the implementation of pharma serialization in 2017. The first phase included a transition period during which 2D DataMatrix codes were allowed...
Read More